Treatment of Phalangeal Bone Defect Using Autologous Stromal Vascular Fraction from Lipoaspirated Tissue.
- Author:
Taewon JEONG
1
;
Yi Hwa JI
;
Deok Woo KIM
;
Eun Sang DHONG
;
Eul Sik YOON
Author Information
1. Department of Plastic Surgery and Reconstructive Surgery, Korea University College of Medicine, Ansan, Korea. yesanam2@korea.ac.kr
- Publication Type:Original Article
- Keywords:
Stromal vascular fraction;
Adipose stem cells;
Bone;
Adipose tissue
- MeSH:
Adipose Tissue;
Adult;
Bone Density;
Bone Matrix;
Durapatite;
Fingers;
Follow-Up Studies;
Hand Injuries;
Humans;
Hypogonadism;
Male;
Mesenchymal Stromal Cells;
Microvessels;
Mitochondrial Diseases;
Ophthalmoplegia;
Osteoblasts;
Osteogenesis;
Polymers;
Regenerative Medicine;
Stromal Cells;
Subcutaneous Fat;
Surgical Procedures, Operative;
Syringes;
Tissue Therapy
- From:Journal of the Korean Society of Plastic and Reconstructive Surgeons
2011;38(4):438-444
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Adipose-derived stromal cells (ASCs) are readily harvested from lipoaspirated tissue or subcutaneous adipose tissue fragments. The stromal vascular fraction (SVF) is a heterogeneous set of cell populations that surround and support adipose tissue, which includes the stromal cells, ASCs, that have the ability to differentiate into cells of several lineages and contains cells from the microvasculature. The mechanisms that drive the ASCs into the osteoblast lineage are still not clear, but the process has been more extensively studied in bone marrow stromal cells. The purpose of this study was to investigate the osteogenic capacity of adipose derived SVF cells and evaluate bone formation following implantation of SVF cells into the bone defect of human phalanx. METHODS: Case 1 a 43-year-old male was wounded while using a press machine. After first operation, segmental bone defects of the left 3rd and 4th middle phalanx occurred. At first we injected the SVF cells combined with demineralized bone matrix (DBM) to defected 4th middle phalangeal bone lesion. We used P (L/DL)LA [Poly (70L-lactide-co-30DL-lactide) Co Polymer P (L/DL)LA] as a scaffold. Next, we implanted the SVF cells combined with DBM to repair left 3rd middle phalangeal bone defect in sequence. Case 2 was a 25-year-old man with crushing hand injury. Three months after the previous surgery, we implanted the SVF cells combined with DBM to restore right 3rd middle phalangeal bone defect by syringe injection. Radiographic images were taken at follow-up hospital visits and evaluated radiographically by means of computerized analysis of digital images. RESULTS: The phalangeal bone defect was treated with autologous SVF cells isolated and applied in a single operative procedure in combination with DBM. The SVF cells were supported in place with mechanical fixation with a resorbable macroporous sheets acting as a soft tissue barrier. The radiographic appearance of the defect revealed a restoration to average bone density and stable position of pharyngeal bone. Densitometric evaluations for digital X-ray revealed improved bone densities in two cases with pharyngeal bone defects, that is, 65.2% for 4th finger of the case 1, 60.5% for 3rd finger of the case 1 and 60.1% for the case 2. CONCLUSION: This study demonstrated that adipose derived stromal vascular fraction cells have osteogenic potential in two clinical case studies. Thus, these reports show that cells from the SVF cells have potential in many areas of clinical cell therapy and regenerative medicine, albeit a lot of work is yet to be done.
